The report "Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027", is projected to reach USD 4.5 billion by 2027 from USD 3.2 billion in 2022, at a CAGR of 7.8%.
Browse 342 market data Tables and 56 Figures spread through 361 Pages and in-depth TOC on "Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-image-analysis-software-market-846.html
The major factors driving the medical image analysis market during the forecast period include technological advancements in medical imaging systems and analysis software, growing public- and private-sector investments in the medical imaging market, the rising prevalence of chronic diseases, and growing applications of computer-aided diagnosis. On the other hand, budgetary constraints are expected to restraint market growth.
In this report, the medical image analysis software market is classified into six segments—type, image type, modality, application, end user, and region.
Integrated software segment to dominate the market in 2021.
The integrated software segment occupied a larger share of the medical image analysis software market in 2021. The segment is also expected to exhibit the highest CAGR during the forecast period. The large share of this segment can be attributed to the benefits of integrated software, such as cost-effectiveness, centralized data storage, and access to live data for multiple users to process, are also expected to support the growth of this segment.
By image type, the 3D imaging segment was the larger market share in 2021.
The 3D imaging segment accounted for the larger share of the medical image analysis software market in 2021. This segment is expected to maintain its leading position throughout the forecast period owing to technological advancements in 3D imaging technology, such as artificial intelligence and machine learning, enabling efficient and accurate real-time visualization of the human body, thereby eliminating distortion in procedures.
Tomography segment expected to have the largest market share in 2021.
The tomography segment accounted for the largest share of the medical image analysis software market in 2021. Technological advancements like 4D imaging systems and software, artificial intelligence, and hybrid imaging modalities; software modifications; and the growing number of CT scanner installations across the globe are expected to drive the tomography segment during the forecast period.
North America to occupy the largest share of the medical image analysis software market in 2021
The medical image analysis software market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East Africa.
North America accounted for the largest share of the medical image analysis software market in 2021. Favorable government initiatives to support the adoption of healthcare IT, and the presence of key market players are favorable factors for market growth in this region.
Asia Pacific was the fastest growing region, which can be attributed to the growing medical imaging research, and increasing adoption of medical image analysis software by healthcare professionals in the region.
Key players offering medical image analysis software products in this market include GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Canon Inc. (Japan), Agfa HealthCare (Belgium), International Business Machines Corporation (US), Carestream Health, Inc. (US), AQUILAB SAS (France), Esaote S.p.A. (Italy), MIM Software, Inc. (US), Image Analysis, Ltd. (UK), and ScienceSoft USA Corporation (US).
These companies adopted strategies such as service launches, business expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their presence in the medical image analysis software market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian